+91 789 2456 581 | info@nckpharma.com

Pharma News

Keep updating your pharma knowledge
13 Sep 2017

What is difference between 351(a) vs. 351(k) pathway?

351(a) is the original approval pathway for biologics. It is the pathway for approval of innovator biologics. It is also known as the traditional pathway for approval of innovator biopharmaceuticals.

351(k) biologics license application is the biosimilar application process in USFDA. Read more

Leave a Reply

Biotech & Biosimilar Regulatory Affairs and Strategic Management

Lorem ipsum dolor sit amet, consectetur adipiscing elit.

1 Month Certification Program